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A b s t r a c t  
Purpose: The objective of the current study was to investigate the role of disintegrants in modulation 
of drug release from HPMC-based hydrophilic matrices. Methods: The polymer matrices of a water-
soluble drug, Propranolol hydrochloride, were prepared in combination with different disintegrants by 
wet-granulation approach. The widely used superdisintegrants like crospovidone (CP), 
croscarmellose sodium (CCS), calcium carboxymethyl cellulose (CaCMC) and sodium starch 
glycolate (SSG) were investigated for their potential role as release modifiers. The polymer-
disintegrant combinations were evaluated for in-vitro drug-release behaviour at various pH 
conditions coupled with determination of swelling behaviour and gel properties of matrices through 
texture analysis. Results: The polymer-disintegrant combinations provided control over initial release 
rate and also exhibited complete drug release over 24 h. The work of penetration of hydrogels after 
24 h dissolution study revealed that formulation with croscarmellose sodium showed complete 
relaxation of gel which fostered the complete drug release. Drug-release from the developed 
combination matrices was observed to be primarily Fickian diffusion based, except for combination 
of HPMC- sodium starch glycolate based matrices, where non-Fickian behaviour was observed. 
Barring sodium starch glycolate, all other polymer-disintegrant combinations provided pH-
independent drug release. The accelerated stability studies of optimized HPMC-disintegrant matrix 
system were also satisfactory. Conclusions: The results of this study suggest that a suitable 
disintegrant when used in combination with HPMC, could modulate the drug-release and also 
synergize the release-controlling properties of hydrogel matrix systems. These findings can certainly 
be applied to develop controlled-release hydrogel matrix system of other highly water-soluble drug 
candidates, and hold a great potential in development of cost-effective and stable HPMC-matrix 
systems with customized drug-release behaviour.  
Keywords: Propranolol hydrochloride, hydrophilic matrices, swelling, disintegrant, release kinetics. 
Introduction 
Hydrogels are three dimensional, hydrophilic, polymeric networks 
capable of swelling in water or biological fluids, and retain a large 
amount of fluid in the swollen state [1,2]. The unique physical 
properties of hydrogels are because of their highly porous structure 
that can be modified by controlling the density of cross-links in the 
gel matrix and their affinity for the aqueous environment in which 
they swell. Their porosity permits loading of drugs into the gel 
matrix and release drug at a rate dependent on the diffusion 
coefficient of the small molecule or macromolecule, through the gel 
network [3]. 
Hydroxypropyl methylcellulose (HPMC), the propylene glycol ether 
of methylcellulose and a water soluble nonionic polymer, is widely 
used excipient for formation of hydrophilic matrix [4]. The drug 
release mechanism and kinetics of hydrophilic matrix system is 
primarily based on aqueous solubility of drug substance and the 
swelling and erosion properties of the polymer [5,6]. Combination 
of anionic and non-ionic polymers has been employed widely to 
control the drug release [7-9]. Further, polymer combination with 
disintegrants, are also reported wherein the presence of a 
disintegrant has been shown to modulate drug release in HPMC-
disintegrant combination matrix [10,11]. 
Disintegrants are indispensable class of excipients for solid oral 
dosage forms, which aid in tablet disintegration and thus help in 
release of active ingredient(s) from the dosage form. Disintegrants 
function by several mechanisms like swelling, wicking or particle 
repulsion. Swelling is the most widely accepted functional 
mechanism for disintegration as almost all disintegrants swell to 
some extent [12].  
In the current study, four different disintegrants 
Carboxymethylcellulose calcium (CaCMC), Crospovidone (CP), 
Croscarmellose sodium (CCS) and sodium starch glycolate (SSG) 
with different functional mechanisms were studied in combination 
with HPMC to explore their potential as release modulator from the 
prepared hydrogel matrix. The key objective was to investigate the 
effect of these different disintegrants on the drug release 
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mechanism from developed HPMC based matrix systems. 
Propranolol Hydrochloride, a BCS class I antihypertensive drug, 
known for its non-selective β-adrenergic blocking activity and short 
plasma half-life (3-5h), was selected as a model drug candidate for 
these investigations [13]. CaCMC is a calcium salt of poly-
carboxymethyl ether of cellulose and it swells several times to that 
of its original bulk when comes in contact with water. CP is a water 
insoluble synthetic cross linked homopolymer of N-vinyl-2-
pyrrolidinone. It acts as a disintegrant because of its high capillary 
activity, hydration capacity and little gel forming tendency. CCS is 
the sodium salt of a cross linked, partly O-(carboxymethylated) 
cellulose, and SSG is the sodium salt of a carboxymethyl ether of 
starch or of a cross-linked carboxymethyl ether of starch. It acts as 
a disintegrant because of its wicking and swellable nature [14,15]. 
Materials and Methods 
Materials 
Propranolol Hydrochloride was obtained from Dr. ReddyÊs 
Laboratories Limited, Hydroxypropyl methylcellulose (HPMC 
K100M) was purchased from Dow Chemical, USA, and Calcium 
Carboxymethylcellulose; E.C.G-505 (CaCMC) was a gift sample 
from Penwest, IA. Crospovidone (Kollidon® CL) was purchased 
from BASF, Mumbai, India. Croscarmellose sodium (Ac-Di-Sol,) 
was purchased from FMC biopolymer India. Sodium starch 
glycolate (GLYCOLIS®) was a gift sample from Roquette India 
Private Limited, Mumbai, India. Di-basic calcium phosphate (A-
Tab®) was purchased from Innophos USA. Povidone K-30 (PVP 
K-30) was purchased from ISP (India) Pvt. Limited, Mumbai. 
Colloidal silicon dioxide (Aerosil 200) was obtained from Degussa 
Evonik AG, Germany and Magnesium stearate was purchased 
from Mallinckrodt Specialty Chemicals, Louis, MO, USA. All other 
solvents and chemicals used were of analytical grade. 
Methods 
Preparation of matrix tablet  
Propranolol Hydrochloride, HPMC K100M and the disintegrant 
(CaCMC, Crospovidone, Croscarmellose sodium or Sodium starch 
glycolate) were accurately weighed and sifted through #40 mesh 
ASTM. The binder solution of PVP K-30 in Isopropyl alcohol (IPA) 
was prepared. Wet granulation was performed in high shear mixer 
granulator (HSMG) (M/s. Saral Engineering) with two minutes of 
binder addition time and one minute kneading time. The granules 
were dried in rapid drier (Retsch TG 200) at 40ĈC for 30-40 minutes 
until loss on drying was observed to be less than 2%w/w. The dried 
granules were passed through #25 ASTM mesh and then mixed 
with Dicalcium phosphate and Colloidal silicon dioxide (Aerosil) 
which were earlier sifted through #40 mesh ASTM. The final blend 
was lubricated with Magnesium stearate (# 60 mesh sifted in a 
suitable blender). The lubricated blend was compressed using 27 
station compression machine (M/s. Cadmach Machinery India) with 
12 mm round biconvex punches at a target weight of about 550mg 
or 600mg (as applicable) and with a hardness of 14-16 Kp. The 
formula compositions employed in the current study are compiled 
in Table 1 and process flow chart is depicted in Figure 1 below. 
 
Table 1. Formulations of hydrogel matrix tablets using HPMC and different disintegrants 
Ingredients Formulation Batch Number
F001 F002 F003 F004 F005 F006 F007 F008 F009
Propranolol HCl (mg) 160 160 160 160 160 160 160 160 160
HPMC (K100M) (mg) 80 160 240 80 80 80 80 160 160
CaCMC (mg) -- - - 160 -- -- -- 160 --
CP (mg) -- -- -- -- 160 -- -- -- --
CCS (mg) -- -- -- -- -- 160 -- -- --
SSG (mg) -- -- -- -- -- -- 160 -- 160
PVP-K30 (mg) 58 58 58 58 58 58 58 58 58
IPA (mL) q.s q.s q.s q.s q.s q.s q.s q.s q.s
DCP (mg) 245.8 165.8 85.8 85.8 85.8 85.8 85.8 55.8 55.8
Aerosil (mg) 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2
Magnesium stearate (mg) 5 5 5 5 5 5 5 5 5
Tablet Weight (mg) 550 550 550 550 550 550 550 600 600
HPMC: Hydroxypropyl methylcellulose; CaCMC: Calcium carboxymethyl cellulose; CP: Crospovidone; CCS: Croscarmellose sodium; SSG: 
Sodium starch glycolate; PVP K-30: Povidone K-30; IPA: Isopropyl Alcohol; DCP: Dicalcium Phosphate; Aerosil: Colloidal silicon dioxide  
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Figure 1. Schematic flow of manufacturing process employed for preparation of HPMC-disintegrant hydrogel matrix tablets. 
 
Physicochemical evaluation 
The compressed tablets of different formula compositions were 
evaluated for varied physicochemical parameters such as physical 
appearance, weight variation, thickness, hardness, friability, drug 
content and in-vitro drug release behavior.  
Drug release studies 
In-vitro drug release studies were performed using USP Type I 
(M/s. Lab India Disso 2000) apparatus at 100 rpm. Dissolution 
medium was 900 mL of pH 1.2 HCl (up to 1.5 h) followed by pH 6.8 
phosphate buffer up to 24 h maintained at 37 μ 0.5ĈC. Aliquots of 
the samples were collected at specified intervals and analyzed by 
UV-Visible spectrophotometry (Shimadzu UV-2450) at ʎmax 290 
nm. Dissolution was also performed in other media like 0.01N HCl 
(pH 1.2 for 24 h) and acetate buffer pH 4.5 (for 24 h) to study the 
effect of different pH conditions on drug release.  
In-vitro drug release: data analysis 
In order to have comparative conclusion for drug release profiles 
obtained from different formulations, the drug release data was 
analyzed through computation of various drug release parameters 
viz. time taken to release 50% of the drug (t50%), mean dissolution 
time (MDT) and percent dissolution efficiency at various time points 
(%DEt). 
The t50% values were computed from regression equation obtained 
from percent undissolved versus time curves, generated for 
respective formulations. The MDT values were obtained as per the 
following equation [16]: 
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Mathematical modeling of drug release profile 
Various kinetic models were employed to describe the probable 
release kinetics displayed by HPMC matrices, prepared in 
combination with different disintegrants. These included Zero-
order, First-order, Higuchi and Korsmeyer-Peppas kinetic models 
and are explained by following set of equations: 
Zero-order rate equation (Equation 3), describes the systems 
where the drug release rate is independent of its initial amount 
[16,18]. 
ܯ଴ െ ܯ௧ ൌ ݇଴ݐ
 
                                                                                  
⁄ (3)  
where, M0, Mt are drug amount taken at time equal to zero, and 
amount dissolved at specific time, t, respectively. The term k0 is 
zero order rate constant.  
The first-order equation (Equation 4) describes the release from a 
system where release rate is amount dependent [19]. 
݈݊ ቀܯ଴ ܯ௧
ൗ ቁ ൌ ݇ଵݐ                            
⁄ (4) 
Where, k1 is the first order rate constant. 
Higuchi described the release of drugs from insoluble matrix as a 
square root of time (Equation 5) dependent process, based on 
Fickian diffusion [20]. 
ܯ௧ ൌ ܭ √ݐ              
         ⁄ (5) 
Where, K is the constant reflecting the design variables of the 
system. 
Korsmeyer derived a relationship (Equation 6) which described 
drug release from a polymeric system to find out the mechanism of 
drug release [21]. 
ெ೟
ெಮ
ൌ ݇ ݐ௡                  
⁄ (6)   
Where, M¥ is the drug amount released at infinite time and Mt /M¥ is 
the fraction of drug released at time t, k is the rate constant and n 
is the release exponent that characterizes the mechanism of drug 
release. 
Various drug release rates were computed as per the above 
described models and compared for the mechanism of drug 
release from the developed matrices. 
Swelling studies 
The swelling behavior of the formulations containing polymer alone 
and combination of polymer with different disintegrants (i.e., F001-
F007) was studied. Three tablets of each batch were kept in a 
beaker containing 100 mL distilled water at 37 μ 1o C. At selected 
time points, the tablets were withdrawn, wiped with tissue paper 
and weighed. The rate of uptake of water by the matrix system was 
calculated at predetermined intervals. The swelling index was 
calculated using the following equation [22]: 
ܹܽݐ݁ݎ ݑ݌ݐܽ݇݁ ൌ  ௐ೟ିௐ೚
ௐ೟
 ൈ 100     
                      ⁄(7) 
Where, Wo is initial weight of tablet, and Wt is the weight of the 
tablet at time t. 
Texture analysis 
In addition to water uptake study, the swelling behavior of swollen 
matrices were further evaluated by textural analysis. The samples 
of different formulations (F001, F003, and F004-F007) were placed 
in dissolution vessels under conditions identical to those specified 
for dissolution studies. At the end of 24 h, the swollen matrices 
were patted lightly with tissue paper and subjected to textural 
profiling to obtain force-time profiles indicating work of probe 
penetration into the entire matrix. Textural analysis was performed 
using a TA.XT2i texture analyzer equipped with 50 kg load cell and 
Texture Expert software (Texture Technologies Corp. Scarsdale, 
NY/Stable Micro Systems, Godalming, UK). The force-time profiles, 
associated with the penetration of a 3mm round-tipped steel probe 
into the swollen matrices, were monitored at a data acquisition rate 
of 200 points per second. The total work of penetration, which 
measures the gel strength in response to the resistance generated 
during probe displacement, was determined using equation 8. 
The total work done through penetration =  ܹܶ ൌ ʃܨ݀ܦ  
           ⁄(8) 
Where, W= Work done; F= Force applied; d= Diameter of probe; 
D= Distance travelled  
Stability study 
Stability study was performed as per ICH guidelines on 
combination formulation of HPMC and CCS (F006) as it exhibited 
similar dissolution profile as that of marketed product which was 
considered as comparator, for evaluation in the current study. The 
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samples were stored in induction sealed HDPE (High Density 
Polyethylene) bottles at 40μ2ÀC and 75μ5℅ RH for a period of 3 
months and analyzed for physical properties, drug content and 
drug release profile. 
Results 
Physicochemical evaluation of HPMC-disintegrant 
matrix tablets 
The thickness of matrix tablets varied from 5.77 to 5.96 mm for 
F001-F007 and 6.24-6.28 mm for F008 and F009. The tablet 
weight was observed to be within acceptable limits. The hardness 
was observed within 14.75-15.86 Kp and friability was found to 
vary between 0.11% and 0.35%. The mean value of drug assay for 
all batches was observed to vary between 99.48 to 100.36%.  
Drug release profiles 
Figure 2a and 2b depict the drug release profiles of various 
formulations, manufactured employing either change in amount of 
polymers and/or disintegrants. For comparison, the drug release 
profile of the marketed long acting product of Propranolol 
Hydrochloride was also determined under identical dissolution 
conditions. Table 2 enlists various drug release parameters 
obtained for all formulations. 
 
 
Figure 2. Drug release profiles of developed HPMC-matrix formulations (a) with varying amount of drug:polymer ratio; (b) containing different 
types of disintegrants; (c)  at different pH conditions 
 
Table 2. Drug release parameters derived from drug release profiles for all HPMC-based formulations 
Parameters Formulation Batch Number 
F001 F002 F003 F004 F005 F006 F007 F008 F009 Marketed product
t50%(h) 4.77 5.35 11.41 5.74 5.24 5.36 9.51 15.23 10.71 5.32
MDT (h) 4.69 4.86 7.39 5.71 5.75 5.90 8.67 5.86 7.42 5.03
DE4h (%) 36.6 30.9 18.7 30.1 35.4 28.8 21.6 19.2 19.3 23.9
DE14h (%) 62.1 56.3 35.6 55.9 58.7 56.7 42.4 35.8 37.7 56.6
DE24h(%) 72.2 67.2 47.9 71.0 71.3 70.3 59.3 45.8 50.8 70.1
%DEt: percent dissolution efficiency at various time points, MDT: mean dissolution time and t50%: time taken to release 50% of the drug 
 
Effect of polymer amount 
In order to study the effect of amount of polymer on drug release, 
the drug: polymer weight ratio was varied from 1:0.5 to 1:1.5 in 
batches F001-F003. Figure 2 (a) shows the effect of varying 
amount of HPMC on drug release, along with comparative release 
profile of marketed long acting product of Propranolol 
Hydrochloride.  Table 2 reflects the t50% values for F001-F003 
varying widely in the range of 4.77 to 11.41 h. Further, the 
parameters like MDT, DE4h (%), DE14h (%) and DE24h (%) also 
represent slowing of the drug release profile as the polymer 
amount is increased in the matrices. 
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Effect of disintegrants 
Figure 2(b) portrays the drug release profiles obtained from 
formulations with different types of the disintegrant (F004-F009) 
along with the drug release profile of long acting marketed product. 
F004-F007 are the formulations encompassing varying type of 
disintegrant in the matrices with drug:polymer ratio as 1:0.5 and 
polymer:disintegrant ratio as 0.5:1. F008 and F009 formulations 
were prepared as combination matrices with higher amount of 
polymer (drug:polymer and polymer:disintegrant ratio as 1.0:1.0). 
Effect of pH on disintegrant role on drug release 
Figure 2c depicts drug release profiles of formulations F004-F007 
in dissolution media with different pH conditions. The hydrogel 
matrices formulated in combination with CaCMC, CP and CCS 
showed similar drug release profiles across varied pH range. 
However, polymer-SSG combination matrices exhibited pH-
dependent release with relatively faster drug release profiles in 
dissolution media like 0.01N HCl and acetate buffer (pH 4.5) when 
compared to dissolution medium with initial pH 1.2 (0.01 N HCl for 
1.5 h) followed by pH 6.8 phosphate buffer up to 24 h. 
Drug release kinetics 
The regression parameters obtained after fitting the obtained data 
into various release kinetic models are summarized in Table 3. The 
goodness of fit for various investigated models ranked in the order 
of Higuchi ‘ Korsmeyer-Peppas >First-order > Zero-order. 
 
Table 3. Statistical parameters of various formulations after fitting the data to various drug release kinetic models 
HPMC 
(%) 
Formulations Disintegrant (%) Zero order First order Higuchi Korsmeyer-Peppas
Type % w/w* k0 r2 k1 r2 K r2 n r2
15 F001 - - 10.5 0.7146 -0.0609 0.8870 26.98 0.9847 0.3161 0.9728
30 F002 - - 9.3 0.7763 -0.0525 0.9264 22.48 0.9816 0.3833 0.9669
44 F003 - - 4.4 0.7578 -0.0253 0.8928 15.04 0.9934 0.4985 0.9944
15 F004 CaCMC 29.09 8.7 0.7327 -0.0572 0.9623 23.12 0.9904 0.4488 0.9765
15 F005 CP 29.09 9.5 0.6124 -0.0537 0.9645 23.59 0.9656 0.3407 0.9908
15 F006 CCS 29.09 9.3 0.8601 -0.0571 0.9940 22.87 0.9955 0.4420 0.9869
15 F007 SSG 29.09 5.3 0.7933 -0.0342 0.9444 17.28 0.9999 0.5411 0.9880
30 F008 CaCMC 26.66 3.3 0.6672 -0.0216 0.8922 14.03 0.9926 0.4461 0.9986
30 F009 SSG 26.66 4.7 0.7903 -0.0297 0.9799 15.92 0.9951 0.5151 0.9971
 Marketed product - - 9.4 0.9569 -0.0608 0.9941 22.96 0.9777 0.5781 0.9325
*with respect to total formula weight of the matrix tablet 
CaCMC: Calcium carboxymethyl cellulose; CP: Crospovidone; CCS: Croscarmellose sodium; SSG: Sodium starch glycolate 
Swelling studies 
Figure 3 depicts the graph of swelling index for HPMC matrices 
versus time (up till 24 h) at different polymer amounts ranging from 
15-45%w/w (i.e., F001-F003) as well as HPMC-disintegrant 
matrices (i.e., F004-F007). All formulations exhibited increase in 
swelling uptill 7 h and thereafter decline in swelling indices were 
observed. As evident from graph, matrices with disintegrants 
exhibited higher swellability indices. Higher swelling indices were 
observed for SSG formulation (F007) than formulation with CCS 
(F006).  
 
 
Figure 3. Swelling Index of developed HPMC-matrices with different amounts of polymer and disintegrants 
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Texture analysis 
The total work of penetration, calculated as the area under the 
forceătime curve indicates matrix stiffness or rigidity. For all the 
formulations (F001, F003, F004-F007), the work of penetration is 
graphically represented in Figure 4. It depicts the change in work of 
penetration versus time as the exposure to swelling medium is 
extended and hydration is increased. Figure 5 depicts the force-
time curve for combination matrices after swelling at 24 h. The 
figure suggests lower force applied for the matrix formulated with 
CCS. 
 
 
Figure 4. Comparative trend on work of penetration data obtained through texture analysis on swollen HPMC-disintegrant matrices  
 
Stability studies 
Figure 6 depicts the in-vitro drug release profile at initial time point 
and after 3 months. The % drug content was found to be 100.31% 
and 99.12% at initial and 3M time points during accelerated 
stability condition of 40ĈC μ 2ĈC/75% RH μ 5% RH. 
 
 
 
                                        Figure 6. In-vitro drug release profile of the Formulation F006 at initial and 3 monthsÊ time point 
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Discussion 
The physicochemical parameters of the tablets viz. average weight, 
thickness, hardness, friability and assay were found to be within 
acceptable limits.  
Drug release profile  
The results of drug release profiles and the computed drug release 
parameters are discussed below: 
Effect of polymer amount  
Formulations with drug:polymer ratio as 1:0.5 and 1:1 (F001 and 
F002, respectively) exhibited initial burst release with incomplete 
release at 24 h, indicating initial fast release of the water-soluble 
drug followed by release retardation due to delayed swelling of the 
polymer (Figure 2a). More release retardation was observed with 
further increase in the polymer amount i.e., formulation with 
drug:polymer ratio as 1:1.5 (F003). The formulation F003 exhibited 
desired control of initial burst release due to increase in polymer 
amount, but, with incomplete extent of drug release in 24 h. The 
%DE values at various times also revealed that drug release from 
Formulation F001 (drug:polymer weight ratio 1:0.5) was quite faster 
than that of Formulation F002 and F003. When compared to 
marketed product for varied %DEt values, Formulation F002 
exhibited faster initial release (%DE4h 30.9>23.9) but showed 
similarity in the later drug release profile. Formulation F003 
however, exhibited retarded and incomplete drug release when 
compared to the marketed product (%DE4h, %DE14h, %DE24h of 
F003 less than those observed for marketed product). The 
observations indicated that release modification with polymer alone 
was inadequate; therefore, to ensure controlled and complete drug 
release, another release modifier was required to be coupled with 
the polymer, which could provide initial control but not hinder the 
extent of drug release with this polymer. 
Effect of disintegrants 
As per data indicated in Table 2 and drug release profiles shown in 
Figure 2a and 2b, all disintegrants except for CP, when coupled 
with polymer in the polymer:disintegrant ratio of 0.5:1 ratio, 
exhibited initial burst control as well as complete release in 24 h. In 
matrices with CP (F005), initial drug release was nearly similar to 
F001 (%DE4h values of F005 similar to that of F001). The 
enhanced control on initial drug release with other disintegrants 
(F004, F006 and F007) was however observed. It could be 
attributed to the rapid swelling of the disintegrant within the matrix, 
which block the pores and hinder the drug release. The drug 
release profiles of these combination matrices could provide 
complete release also, in contrast to F001 and F002 formulations. 
In the later phase of the dissolution, the gel matrices in all 
combination products (i.e., F004-F007) eventually eroded and led 
to nearly complete release of the drug. Values for parameters like 
t50%, %DE14h and %DE24h of formulations F004 to F007, when 
compared to that of formulation F001 indicate slight extension of 
the drug release profile in the combination matrices. Formulation 
with SSG (F007), exhibited relatively more control on initial burst 
release from matrix. This indicated synergizing effect of the 
swellable disintegrants for release retarding effect of HPMC. These 
parameters and profiles were observed to be comparable in 
magnitude to those of F002 formulation indicating that 
disintegrants in combination with lower amount of polymer could 
impart release modulation to the extent similar formulations 
containing higher amount of polymer alone but with added 
advantage of complete extent of drug release. 
The study on effect of disintegrants CaCMC (F008) and SSG 
(F009) when coupled with higher amount of polymer (drug:polymer 
and polymer:disintegrant ratio as 1:1) revealed not only initial drug 
release control (%DE4h values as 19.2 for F008 and 19.3 for F009 
vs. 30.9 for F002), but the extent was also observed to be retarded 
with corresponding %DE24h values as 45.8 for F008 and 50.8 for 
F009 versus 67.2 for F002. This indicated that disintegrants with 
higher polymer amount helped in controlling not only the initial 
burst but also synergized release retardation at later phase of 
dissolution and thereby resulting in incomplete release at 24 h. 
Therefore, the disintegrant should be paired with lower amount of 
HPMC only. The combination matrices formulated with polymer 
and CaCMC and CCS (F004, F006) exhibited similar drug release 
profile as that obtained with the marketed product. 
Effect of pH on disintegrants role as release modulator  
As evident from graph (Figure 2c), the formulations (F004-F006) 
with disintegrants CaCMC, Crospovidone and CCS provided pH 
independent control on initial and complete release in 24 h. 
However, formulation with SSG (F007) exhibited relatively faster 
initial release in dissolution media like 0.01N HCl and acetate 
buffer (pH 4.5) in comparison to that obtained in medium with 
0.01N (pH 1.2 for 1.5 h) followed by pH 6.8 phosphate buffer 
thereafter. HPMC-disintegrant matrix prepared with SSG exhibited 
faster initial release which may be attributed to anionic nature of 
the disintegrant. Mixed reports are available on pH dependent 
disintegrant effect of CCS and SSG in literature [12, 23-25]. 
Drug release kinetics 
High values for goodness of fit for Higuchi model reflected drug 
release mechanism to be primarily diffusion based. All models 
except for Zero-order were fitted considering the entire drug 
release profile i.e., up till 24 h. Since the extent of release varied at 
given time points, modeling analysis for zero-order was carried out 
by fitting the data up till about 70 % of the drug release. The drug 
release from all formulations was governed by Fickian diffusion 
except for formulation with higher polymer content (F003) and 
HPMC-SSG matrix formulations (F007 and F009). The latter 
formulations exhibited non-Fickian behavior, which showed a 
combination of diffusion as well as erosion mechanisms of drug 
release.  
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Swelling studies 
Higher swelling propensity was observed with combination 
matrices (Figure 3).The swelling indices for each formulation were 
observed to increase till 7 h, which could be due to strong gelation 
of hydrogel tablets [26]. Tablet weights increased proportionally 
with rate of hydration over a period of time. Later on, they tended to 
decrease gradually due to erosion of outermost gelled layer of 
tablet into dissolution medium. These results were in consonance 
with earlier findings, which reported that disintegrants due to higher 
hydration rate and capillary action increased the penetration of 
water into the hydrophilic matrices leading to higher swelling index 
[12, 27]. Consequently, greater extents of swelling at a higher 
amount of polymers lead to increase in the tablet dimensions and 
increasing the diffusion pathways and thus decreasing the 
dissolution rates. 
After peak hydration at 7 h, swollen matrices start to erode 
because inter-chain molecular forces of highly swollen polymers 
are not able to resist any external force. Upon erosion, the matrix 
system tends to breaks into smaller particles, leading to more drug 
release (26). The swelling index order of various disintegrants in 
combination matrices was observed to be SSG > CCS > CaCMC > 
CP.  Higher swelling index were observed for SSG formulation 
(F007) than formulation with CCS (F006). However, the formulation 
with SSG was observed to have less physical integrity than F006. 
The Formulations F004 and F005 containing CaCMC and CP, 
respectively were observed to gelate slowly when compared to the 
formulations with other two disintegrants. This could be related to 
relatively faster initial drug release as well. However, these 
formulations were able to maintain the integrity of the hydrogel 
formed for the desired period of time unlike formulation with SSG 
(F007) thus rendering the extended and complete release of the 
drug.  
Texture analysis 
The combination hydrogels formulated with disintegrants (F004-
F007) exhibited relatively higher value of work of penetration in 
comparison to hydrogels formulated without them (F001 and 
F003). This indicated relatively faster swelling in their presence 
leading to more gelation and consequently in higher work of 
penetration. The order for work of penetration of various 
disintegrants in combination matrices was observed to be SSG > 
CaCMC > CP > CCS (Figure 5). Due to presence of swellable 
polymers in the hydrogel matrices, the matrix system easily 
absorbed water and swelled significantly upon contact with water. 
Based on the type of swellable polymer and the amount used, the 
hydrogel formation and its dynamics vary [28]. The formation of 
hydrogel on the surface of matrix generally undergoes transition 
phases, from a glassy (dry) stage where the mobility of drug and 
the hydrophilic polymer is very low (owing to the solid compressed 
state), to a rubbery (wet) stage where the mobility of the polymer 
and drug substance is increased due to which drug diffusion takes 
place [29]. The formulations with no disintegrants showed that 
matrices exhibited lower work of penetration (Figure 4). In the 
formulations with disintegrants, the gelation occurred slowly and 
prolonged the drug release. Figure 4 showed that for all HPMC-
disintegrant combination matrix formulations, work of penetration 
values were high at the initial time point and as the gelation of the 
hydrogel matrix progressed, the work of penetration values 
decreased and were low at 24 h as the hydrogel completely 
relaxed. Unlike swelling studies, F004 was however observed to 
exhibit work of penetration values comparable to other swellable 
disintegrants like CCS and SSG. Overall during swelling studies, 
the matrix swelling was observed to increase uptill 7 h. Such trend 
was however not observed in the textural analysis. This indicated 
that as the time lapsed, the swollen matrices simultaneously 
started eroding in turn losing the gel strength. This could have 
facilitated the complete release of drug over the studied time period 
of 24 h. Amongst all formulations, F006 containing CCS was 
observed to have least work of penetration value at the end of 24 h 
thus showing the complete relaxation of the hydrogel system and 
complete release of the water soluble drug from the developed 
matrix system (Figure 5). 
Stability studies 
Based on similarity in release profile, swelling studies and textural 
analysis, formulation F004 and F006 seemed to be promising 
combinations to achieve desired drug release profile. Stability 
study data for formulation F006, is presented here. No significant 
changes in physicochemical parameters and in-vitro drug release 
were observed in formulation F006, after 3 months of storage at 
40μ2ÀC &75μ5℅ RH, indicating adequate drug product stability in 
the studied packaging configuration.  
Conclusions 
In the current work, the potential role of different disintegrants on 
release modulation of water soluble drug from HPMC matrix was 
investigated. The results have suggested that higher viscosity 
grade hydrophilic polymer alone was inadequate in providing the 
complete drug release along with control over initial rate. 
Combination of Polymer-disintegrant however, was able to provide 
complete drug release with varying degree of control over initial 
burst release. The drug release rates correlated with swelling 
properties of the matrices wherein disintegrant also played a key 
role. Overall, drug release was Fickian diffusion based except for 
SSG formulations where non-Fickian behavior was observed. 
Except for SSG based HPMC matrix, all polymer-disintegrant 
combinations showed pH-independent release. Texture analysis 
studies revealed the minimum work of penetration at 24 h for CCS 
formulation followed by other three formulations in the order of 
CP<CaCMC<SSG. High swelling indices associated with CCS 
formulation coupled with lower penetration work values indicated 
the drug release by both diffusion as well as polymer relaxation. 
Formulation with HPMC-CCS combination provided similar drug 
release to that of marketed product, and also showed good stability 
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over accelerated 3 months stability study. The findings of the 
current study suggest that polymer-disintegrant combinations can 
be successfully exploited to control or modulate the drug release 
from the HPMC matrices of other highly water soluble drugs as 
well.  
AuthorsÊ Contributions 
Sanjay Wagh has carried out the research work and compiled the 
study findings. This research work has been carried out under the 
supervision of Jayanthi Kumar. Both the authors have read and 
approved the final manuscript. 
Acknowledgements 
The authors wish to thank Dr. Reddy's Laboratories Ltd. Bollaram 
Road, Miyapur, Hyderabad ă 500049, India for providing necessary 
research facilities and support for carrying out this research work. 
 
 
References 
 
[1]. Maderuelo C, Zarzuelo A and Lanao JM. 
Critical factors in the release of drugs 
from sustained release hydrophillic 
matrices. J. Control. Release, 2011;154: 
2-19. 
[2]. Gaetano L. Parametric simulation of 
drug release from hydrogel-based 
matrices.  J Pharm Pharmacol, 2012; 4; 
641:48-51.  
[3]. Todd RH, Daniel SK. Hydrogels in drug 
delivery: Progress and challenges, 
Polymer, 2008; 49:1993-2007.   
[4]. Siepmann J, Peppas NA. Modelling of 
drug release from delivery systems 
based on Hydroxypropyl Methylcellulose 
(HPMC). Adv Drug.Del, 2001; 48 2-
3:139-157. 
[5]. Hardy IJ, Windberg BA, Neri C, Byway 
PV, Booth SW, S Fitzpatrick. Modulation 
of drug release kinetics from 
Hydroxypropyl Methyl Cellulose matrix 
tablets using polyvinyl pyrrolidone. Int 
Journ Pharm, 2007; 337 1-2: 246-253.  
[6]. Bendgude NT, Iyer VR and Poddar SIS. 
The Effects of Lactose, Microcrystalline 
Cellulose and Dicalcium Phosphate on 
Swelling and Erosion of Compressed 
HPMC Matrix Tablets: Texture Analyzer, 
Iranian Journal of Pharmaceutical 
Research, 2010; 9 4: 349-358.  
[7]. Baveja SK, Ranga Rao KV, Devi KP.  
Zero-order release hydrophilic matrix 
tablets of β-adrenergic blockers.  Int J 
Pharm, 1987; 39: 39ă45. 
[8]. Dabbagh MA, Ford JL, Rubinstein MH, 
Hogan JE, Rajabi-Siahboomi AR. 
Release of propranolol hydrochloride 
from matrix tablets containing sodium 
carboxymethylcellulose and 
Hydroxypropyl methylcellulose. Pharm 
Dev Technol, 1999; 4: 313-324. 
[9]. Rao MY, Veni JK and Jayasagar G. 
Formulation and Evaluation of 
Diclofenac Sodium Using Hydrophilic 
Matrices. Drug Development and 
Industrial Pharmacy, 2001; 27,8, 759ă
766 
[10]. Vaidya MP, Avachat AM. Investigation of 
the impact of insoluble diluents on the 
compression and release properties of 
matrix based sustained release tablets, 
Powder Technology, 2011; 214: 3-25, 
375ă381. 
[11]. Qing RC, Yun WC, Jing HC, Beom JL. 
Formulation, release characteristics and 
bioavailability of novel monolithic 
Hydroxypropyl methylcellulose matrix 
tablets containing acetaminophen. 
Journal of Controlled Release, 
2005;108: 351ă361. 
[12]. Zhao Na, Larry LA. The influence of 
swelling capacity of superdisintegrants 
in different pH media on the dissolution 
of hydrochlorothiazide from directly 
compressed tablets. AAPS Pharm Sci 
Tech, 2005; 6 1: E120-6. 
[13]. Serlin MJ, Orme ML, Maclver M, Green 
GJ, Sibeon RG, and Breckenridge AM. 
The pharmacodynamics and 
pharmacokinetics of conventional and 
long-acting propranolol in patients with 
moderate hypertension, Br J Clin 
pharmacol, 1983;15,5: 519-527. 
[14]. Atsushi K, Hirokazu T, Kunikazu M, Keiji 
Y. Improvement of HPMC tablet 
disintegration by the addition of 
inorganic salts. Chem. Pharm. Bull, 
2008; 56, 4:598-601. 
[15]. Oluwatoyin AO and Babatunde LA. 
Effect of the mode of incorporation on 
the disintegrant properties of acid 
modified water and white yam starches. 
Saudi Pharm J, 2012; 20,2: 171ă175. 
[16]. Sathe PM, Tsong Y, Shah VP. In-vitro 
dissolution profile comparison. In: 
Encyclopedia of Biopharmaceutical 
Statistics. New York: Marcel Dekker. 
2003;456-462. 
[17]. Khan KA. The concept of dissolution 
efficiency. J. Pharm. Pharmacol, 1975; 
27: 48-49. 
[18]. Themistocles PH, Gary DC, Michael AK, 
Panayotis EM. Quantitative Calculations 
in Pharmaceutical Practice and 
Research. VCH Publishers.Inc, New 
York. 1993; 345-348.  
[19]. Bourne DWA. Pharmacokinetics. In 
Banker GS, Rhodes CT Modern 
Pharmaceutics, Eds., Marcel Dekker, 
New York, NY, USA, 4th edition; 2002. 
67ă92. 
[20]. Higuchi T. Mechanism of sustained 
action medication. Theoretical analysis 
of rate of release of solid drugs 
dispersed in solid matrices. J.Pharm Sci, 
1963;52: 1145-1149. 
[21]. Richard WK, Robert G, Eric D, Pierre B, 
Nikolaos AP. Mechanisms of solute 
release from porous hydrophilic 
Wagh, International Journal of Drug Delivery 7 (2) 90-100 [2015] 
 
 
  
PAGE | 100 |
 
polymers. Int. J. Pharm, 1983; 15: 25-
35.   
[22]. Peniche C, Elvira C, Roman JS. 
Interpolymer complexes of chitosan and 
polymethacrylic derivatives of salicylic 
acid: Preparation, characterization and 
modification by thermal treatment. 
Polymer, 1998; 39:6549ă6554. 
[23]. Zhao Na, Augsberger LL Functionality 
comparison of 3 classes of 
superdisintegrants in promoting aspirin 
tablet disintegration and dissolution. 
AAPS PharmSci Tech, 2005; 6. 
[24]. Mohamad A, Dashevsky A. pH 
independent pulsatile drug delivery 
system based on hard gelatin capsules 
and coated with aqueous dispersion 
Aquacoat ECD.  Eur J Phar. Biopharm, 
2006; 64, 173.   
[25]. Gordon MS, Rudraraju VS, Dani K, 
Chowhan ZT. Effect of the mode of 
super disintegrant incorporation on 
dissolution in wet granulated tablets. J 
Pharm Sci, 1993; 82,2:220-6. 
[26]. Omidian H, Park K. Swelling agents and 
devices in oral drug delivery. J Drug Del 
Sci Tech, 2008; 18,2: 83-93.  
[27]. Mostafavi A, Emami J, Varshosaz J. 
Davies NM. Rezazadeh M. Development 
of a prolonged-release gastroretentive 
tablet formulation of ciprofloxacin 
hydrochloride: Pharmacokinetic 
characterization in healthy human 
volunteers.  International Journal of 
Pharmaceutics, 2011; 409: 128ă136. 
[28]. Paolo C, Ruggero B, Patrizia S, 
Nikolaos AP. Swellable matrices for 
controlled drug delivery: gel-layer 
behaviour, mechanisms and optimal 
performance, Pharma Sci & Tech 
Today, 2000;3,6: 198ă204. 
[29]. Hongato Li, Xiaochen Gu. Correlation 
between drug dissolution and polymer 
hydration: A study using texture 
analysis. International Journal of 
Pharmaceutics. 2007; 342,1-2:18-25. 
  
 
 
